Under the leadership of John Ramunas and Glenn Markov, Rejuvenation Technologies is developing RTI-LIV for Alcoholic Hepatitis. Their focus is on reversing telomere shortening, a fundamental hallmark of aging, to combat age-related diseases.
×
Rejuvenation Technologies � RTI-LIV (Alcoholic Hepatitis)
© 2021 - Lifespan Extension Advocacy Foundation - LIFESPAN2023
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.
Powered by MMD